SCHEMBL9570990

SCHEMBL9570990

COc1ccc(Cl)cc1N1CCN(CC(CNc2nccc(C(N)=O)n2)OC)CC1

nearest known ligand 0.72

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 8/20 0.72
ADRA1A P35348 8/20 0.72
ADRA1B P35368 8/20 0.72
HTR1A P08908 5/20 0.41
LMNA P02545 1/20 0.41
TACR3 P29371 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
IDH1 O75874 1/20 0.39
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
SLC2A1 P11166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9017186 0.91 ADRA1D (0.73) ADRA1DADRA1AADRA1BHTR1ALMNA
Hydrochloric Acid SCHEMBL9586428 0.90 ADRA1D (0.72) ADRA1DADRA1AADRA1BHTR1ALMNA
SCHEMBL9200004 0.85 ADRA1A (0.90) ADRA1DADRA1AADRA1BHTR1ALMNA
SCHEMBL9192958 0.84 ADRA1A (0.69) ADRA1DADRA1AADRA1BHTR1ALMNA
SCHEMBL9195086 0.84 ADRA1D (0.63) ADRA1DADRA1AADRA1BHTR1ALMNA
SCHEMBL5597266 0.84 ADRA1D (1.00) ADRA1DADRA1AADRA1BHTR1ALMNA
SCHEMBL9199034 0.81 ADRA1A (0.62) ADRA1DADRA1AADRA1BHTR1ALMNA
SCHEMBL9017200 0.81 ADRA1D (0.59) ADRA1DADRA1AADRA1BHTR1AADRB2
SCHEMBL9585946 0.80 ADRA1D (0.58) ADRA1DADRA1AADRA1BHTR1ALMNA
Fumaric Acid SCHEMBL5459952 0.80 ADRA1D (0.91) ADRA1DADRA1AADRA1BHTR1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5244901-A Multistage preparation by starting with a phenylpiperazine and an epoxide or chloro alcohol containing a phthalimido group; use to treat disorders involving hyperactivity of the alpha 1-adrenergic system SYNTHELABO (FR) 1993-09-14 US disclosed
EP-0522915-A1 Pyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-13 EP disclosed